scholarly article | Q13442814 |
P50 | author | Yago Nieto | Q85372325 |
Muzaffar Qazilbash | Q87088891 | ||
Elizabeth J Shpall | Q87373605 | ||
Stefan O Ciurea | Q87848230 | ||
Richard E Champlin | Q89187648 | ||
Roland L Bassett | Q91497807 | ||
Partow Kebriaei | Q104745054 | ||
Gabriela Rondon | Q114427983 | ||
Rima M Saliba | Q114428014 | ||
Laura Worth | Q114428072 | ||
John McMannis | Q116793080 | ||
Demetrios Petropoulos | Q117233466 | ||
Roy B. Jones | Q122694370 | ||
Chitra Hosing | Q37840480 | ||
Nelson Hamerschlak | Q42383096 | ||
Marcelo A. Fernández-Viña | Q59750308 | ||
Amado Karduss-Urueta | Q73549352 | ||
P2093 | author name string | Manish Sharma | |
Marcos de Lima | |||
Daniel R Couriel | |||
Ka Wah Chan | |||
P2860 | cites work | Outcomes among 562 recipients of placental-blood transplants from unrelated donors | Q77598678 |
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies | Q80066587 | ||
Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation | Q31828080 | ||
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution | Q33819877 | ||
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. | Q33841389 | ||
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells | Q33858964 | ||
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial | Q33861192 | ||
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors | Q33951486 | ||
Donor-derived second hematologic malignancies after cord blood transplantation | Q33952705 | ||
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival | Q34144410 | ||
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantation | Q34510349 | ||
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation | Q35073502 | ||
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing | Q36447936 | ||
Chronic graft-versus-host disease and other late complications of bone marrow transplantation. | Q37295704 | ||
Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients | Q39258753 | ||
1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
The Analysis of Failure Times in the Presence of Competing Risks | Q41031423 | ||
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation | Q42154867 | ||
Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia. | Q43278450 | ||
Unrelated umbilical cord blood transplantation in adult patients | Q44694397 | ||
High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan | Q46807795 | ||
A Survey of Exact Inference for Contingency Tables | Q56432188 | ||
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy | Q56777948 | ||
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients | Q71133353 | ||
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases | Q74106097 | ||
P433 | issue | 5 | |
P921 | main subject | thymocyte | Q7799635 |
P304 | page(s) | 901-906 | |
P577 | publication date | 2012-01-03 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant | |
P478 | volume | 53 |
Q43156049 | A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm |
Q36905573 | A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation |
Q53315058 | Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. |
Q36622322 | High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia |
Q49218292 | High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation. |
Q85830183 | Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies |
Q44756831 | Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database |
Search more.